Global Retirement Partners LLC Has $54,000 Position in SPDR S&P Biotech ETF (XBI)

Global Retirement Partners LLC lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 93.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 754 shares of the exchange traded fund’s stock after selling 10,322 shares during the period. Global Retirement Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $54,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in XBI. Equitable Trust Co. increased its stake in SPDR S&P Biotech ETF by 2.6% during the 4th quarter. Equitable Trust Co. now owns 5,121 shares of the exchange traded fund’s stock valued at $367,000 after buying an additional 129 shares during the period. Psagot Investment House Ltd. acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $3,117,000. Advisory Services Network LLC grew its stake in shares of SPDR S&P Biotech ETF by 705.6% in the 4th quarter. Advisory Services Network LLC now owns 1,740 shares of the exchange traded fund’s stock worth $125,000 after purchasing an additional 1,524 shares during the last quarter. HRT Financial LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 100.7% in the fourth quarter. HRT Financial LLC now owns 82,754 shares of the exchange traded fund’s stock worth $5,937,000 after buying an additional 41,528 shares during the period. Finally, Oak Grove Capital LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 12.7% in the fourth quarter. Oak Grove Capital LLC now owns 14,150 shares of the exchange traded fund’s stock worth $1,015,000 after buying an additional 1,600 shares during the period.

Shares of XBI opened at $90.43 on Tuesday. SPDR S&P Biotech ETF has a one year low of $64.38 and a one year high of $101.55.

COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://sportsperspectives.com/2019/04/02/global-retirement-partners-llc-has-54000-position-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: How are dividend achievers different from dividend aristocrats?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.